IRIDEX Corp. Daily Stock Analysis

Daily Stock Analysis, IRIX, IRIDEX Corp, priceseries

IRIDEX Corp. Daily Stock Analysis
Stock Information
Open
4.39
Close
4.25
High
4.59
Low
4.25
Previous Close
4.35
Daily Price Gain
-0.10
YTD High
6.48
YTD High Date
Jan 3, 2022
YTD Low
3.69
YTD Low Date
Feb 23, 2022
YTD Price Change
-2.17
YTD Gain
-33.80%
52 Week High
9.71
52 Week High Date
Apr 27, 2021
52 Week Low
3.69
52 Week Low Date
Feb 23, 2022
52 Week Price Change
-2.22
52 Week Gain
-34.31%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Sep 18. 2017
9.87
Sep 21. 2017
10.43
3 Trading Days
5.62%
Link
LONG
May 8. 2018
6.41
May 29. 2018
7.02
14 Trading Days
9.54%
Link
LONG
Jul 18. 2018
6.70
Aug 1. 2018
7.10
10 Trading Days
6.02%
Link
LONG
Aug 22. 2018
8.19
Sep 7. 2018
8.76
11 Trading Days
6.97%
Link
LONG
Jan 13. 2020
2.36
Jan 23. 2020
2.90
7 Trading Days
23.05%
Link
LONG
Jun 1. 2020
1.92
Jun 11. 2020
2.27
8 Trading Days
18.22%
Link
LONG
Jan 7. 2021
2.52
Jan 27. 2021
4.86
13 Trading Days
92.91%
Link
Company Information
Stock Symbol
IRIX
Exchange
NasdaqGM
Company URL
http://www.iridex.com
Company Phone
6509404700
CEO
William M. Moore
Headquarters
California
Business Address
1212 TERRA BELLA AVE, MOUNTAIN VIEW, CA 94043
Sector
Equity
Industry Category
Health Services
Industry Group
Medical Appliances & Equipment
CIK
0001006045
About

IRIDEX Corp. engages in the development and commercialization of products and procedures used to treat sight-threatening eye conditions. Its products consist of laser consoles, delivery devices and consumable instrumentation, including laser probes. It operates through the following geographical segments: United State, Europe, Rest of Americas, and Asia/Pacific Rim. he company was founded by Eduardo Arias, Theodore A. Boutacoff, and James L. Donovan in February 1989 and is headquartered in Mountain View, CA.

Description

IRIDEX Corporation provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. The company offers laser consoles, such as Cyclo G6 laser system used for the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of diabetic macular edema and other retinal diseases; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser systems, which are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. It also provides delivery devices, including TxCell scanning laser delivery system that allows the physicians to perform multi-spot pattern scanning; Slit Lamp Adapter, which allows the physicians to utilize a standard slit lamp in diagnosis and treatment procedures; and TruFocus laser indirect ophthalmoscopes for use in procedures to treat peripheral retinal disorders. In addition, the company offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system that delivers laser to treat glaucoma; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe Illuminate that is used in procedures to treat refractory glaucoma; and EndoProbe family of products used in vitrectomy procedures. It serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, and office clinics. IRIDEX Corporation markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was founded in 1989 and is headquartered in Mountain View, California.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading